2016
DOI: 10.1007/s12264-016-0082-1
|View full text |Cite
|
Sign up to set email alerts
|

On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
5
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 27 publications
(39 reference statements)
0
5
0
Order By: Relevance
“…Furthermore, a single bilateral infusion of (R)-ketamine into the infralimbic cortex of the medial prefrontal cortex (PFC) and the cornu ammonis 3 (CA3) and dentate gyrus (DG) of the hippocampus demonstrates antidepressant effects (35), suggesting that these brain regions play a role in the direct antidepressant actions of (R)-ketamine. Unlike (S)-ketamine, (R)-ketamine appears to be independent of psychotomimetic side effects and abuse potential (32,(36)(37)(38).…”
mentioning
confidence: 99%
“…Furthermore, a single bilateral infusion of (R)-ketamine into the infralimbic cortex of the medial prefrontal cortex (PFC) and the cornu ammonis 3 (CA3) and dentate gyrus (DG) of the hippocampus demonstrates antidepressant effects (35), suggesting that these brain regions play a role in the direct antidepressant actions of (R)-ketamine. Unlike (S)-ketamine, (R)-ketamine appears to be independent of psychotomimetic side effects and abuse potential (32,(36)(37)(38).…”
mentioning
confidence: 99%
“…Compared with (S)-ketamine, the (R)-ketamine enantiomer has greater and longer-lasting antidepressant efficacy in several animal models of depression, such as the forced swim test, learned helplessness, and chronic social defeat stress. However, because of inconsistencies with previous studies and controversy regarding the antidepressant actions of ketamine metabolites independent of NMDA receptor inhibition, this conclusion should be treated with caution, and it needs further investigation and verification [18].…”
mentioning
confidence: 79%
“…It is especially intriguing that subanesthetic ketamine has been shown to possess rapid antidepressant effects in both preclinical and clinical studies [35][36][37]. Abundant epidemiological data have revealed high comorbidity of drug addiction and major depression [38]; therefore, the above results suggest that subanesthetic ketamine could be especially effective to treat the comorbidity of drug addiction and depression [39]. Besides directly modulating the ionotropic glutamate receptors, recent studies have demonstrated promising effects for the use of allosteric modulators of mGluRs in drug addiction [40].…”
Section: Glutamate Systemmentioning
confidence: 99%